287
Views
157
CrossRef citations to date
0
Altmetric
Original Article

Improved Outcome of Zygomycosis in Patients with Hematological Diseases?

, , , &
Pages 1351-1360 | Received 14 Nov 2003, Published online: 03 Aug 2009

Reference

  • Pagano, L., Girmenia, C., Mele, L., Ricci, P., Tosti, M.E., Nosari, A., etal. (2001) "Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases of GIMEMA Infection Program", Haematologica, 86, 862–870.
  • Ribes, J.A., Vanover-Sams, C.L. and Baker, D.J. (2000) "Zygo-mycetes in human disease", Clinical Microbiology Reviews, 13(2), 236— 301.
  • Meyer, RD., Rosen, P. and Armstrong, D. (1972) "Phycomycosis complicating leukaemia and lymphoma", Annals of Internal Medicine, 77, 871–879.
  • Nosari, A., Oreste, P., Montillo, M., Carrafiello, G., Draisci, M., Muti, G., et al. (2000) "Mucormycosis in hematologic malignan-cies: an emerging fungal infection", Haematologica, 85, 1068 — 1071.
  • Peterson, K.L., Wang, M., Canalis, R.F. and Abemayour, E. (1997) "Rhinocerebral mucormycosis: evolution of the disease and treatment options", Larynposcope, 107(7), 855–862.
  • Lee, F.Y., Mossad, S.B. and Adal, K.A. (1999) "Pulmonary mucormycosis: the last 30 years", Archives Internal Medicine, 159(12), 1301–1319.
  • Tedder, M., Spratt, J.A., Anstadt, M.P., Hegde, S.S., Tedder, S.D. and Lowe, J.E. (1994) "Pulmonary mucormycosis: results of medical and surgical therapy", The Annals of Thoracic Surgery, 57, 1044 — 1050.
  • Pagano, L., Ricci, P., Tonso, A., Nosari, A., Cudillo, L., Montillo, M., et al. (1997) "Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases", British Journal of Haematology, 99, 331— 336.
  • Hoelzer, D., Ludwig, W.D., Thiel, E., Gassmann, W., Loftier, H., Fonatsch, C., et al. (1996) "Improved outcome in adult B-cell acute lymphoblastic leukemia", Blood 87(2), 495–508.
  • Schmitz, N., Pfistner, B., Sextro, M., Sieber, M., Carella, A.M., Haenel, M., et al. (2002) "Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemo-poietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial", Lancet 359(9323), 2065 — 2071.
  • Adam, RD., Hunter, G., DiTomasso, J. and Comerci, G. Jr. (1994) "Mucormycosis: emerging prominence of cutaneous infec-tions", Clinical Infectious Diseases, 19(1), 67 — 76.
  • Agh, F., Spanik, G., Gyarfas, J., Horvath, J. and Krcmery, V. Jr. (1992) "Three fatal cases of disseminated mucormycosis associated with respiratory distress syndrome and shock in patients with hematologic malignancies", Infection, 20(2), 112.
  • Auerbach, D.B. and Bilyk, J.R. (1999) "Lung cancer, proptosis, and decreased vision", Survey of Ophthalmology, 43(5), 405 — 412.
  • Aydogdu, I., Sari, R. and Mizrak, B. (2001) "Case report. Rhinocerebral zygomycosis", Mycosis, 44, 59–60.
  • Berenguer, J., Munoz, P., Parras, F., Fernández-Baca, V., Hernández-Sampelayo, T. and Bouza, E. (1994) "Treatment of deep mycoses with liposomal amphotericin B", European Journal of Clinical Microbiology & Infectious Diseases, 13, 504–507.
  • Birchall, D., Leong, W.K. and Mcauliffe, W. (1999) "Cerebral mucormycosis", Journal of Neurology, Neurosurgery, and Psychia-try, 66, 404–405.
  • Bjiirkholm, M., Runarsson, G., Celsing, F., Kahn, M., Petrini, B. and Engervall, P. (2001) "Liposomal amphotericin B and surgery in the successful treatment of invasive pulmonary mucormycosis in a patient with acute T-Iymphoblastic leukaemia", Scandinavian Journal of Infectious Diseases, 33, 316–319.
  • Chakrabarti, A., Panda, N., Varma, S.C., Singh, K., Das, A., Sharma, S.C. and Padhye, A.A. (1997) "Craniofacial zygomycosis caused by Apophysomyces elegans", Mycoses, 40(11–12), 419 — 421.
  • Chan, L.-L., Singh, S., Jones, D., Diaz, E.M. Jr. and Ginsberg, L.E. (2000) "Imaging of Mucormycosis skull base osteomyelitis", American Journal of Neuroradiology, 21, 828 — 831.
  • Chemaly, R.F., Fox, S.B., Alkotob, L.M., Scharpf, J., Sobecks, R., Eliachar, I., et al. (2002) "A case of zygomycosis and invasive candidiasis involving the epiglottis and tongue in an immunocom-promised patient", Scandinavian Journal of Infectious Diseases, 34(2), 149 — 151.
  • Clark, A.D. and Butt, N. (1997) "Ectasy-induced very severe aplastic anemia complicated by invasive pulmonary mucormycosis treated with allogeneic peripheral blood progenitor cell trans-plant", Clinical and Laboratory Haematology, 19(4), 279 — 281.
  • Cloughley, R., Kelehan, J., Corbett-Feeney, G., Murray, M, Callaghan, J., Regan, P. and Cormican, M. (2002) "Soft tissue infection with Absidia corymbifera in a patient with idiopathic aplastic anemia", Journal of Clinical Microbiology, 40(2), 725 — 727.
  • Cuvelier, I., Vogelaers, D., Peleman, R., Benoit, D., Van Marck, V., Offner, F., et al. (1998) "Two cases of disseminated mucormycosis in patients with hematological malginancies and literature review", European Journal of Clinical Microbiology & Infectious Diseases, 17(12), 859–863.
  • Dykhuizen, R.S., Kerr, K.N. and Soutar, R.L. (1994) "Air crescent sign and fatal haemoptysis in pulmonary mucormycosis", Scandi-navian Journal of Infectious Diseases, 26(4), 498 — 501.
  • Elnakadi, I., Mehdi, A., Franck, S., Roger, T., Larsimont, D. and Pector, J.C. (1998) "Cecal infarct: report of a case", Diseases of the Colon and Rectum, 41(12), 1585–1586.
  • Eucker, J., Sezer, 0., Lehmann, R., Weber, J.R., Graf, B., Denkert, C., et al. (2000) "Disseminated Mucormycosis caused by Absidia corymbifera leading to cerebral vasculitis", Infection, 28(4), 246–250.
  • Faber, E., Riegrova, D., Jarosova, M., Hubacek, J., Slezak, P., Pikalova, Z., et al. (1996) "Abdominal zygomycotic thromboan-giitis in a patient with AML and t(1;13;14)", Annals of Hematology, 73(4), 195–198.
  • Ferguson, B.F. (2000) "Mucormycosis of the nose and paranasal sinuses", Otolaryngologic Clinics of North America, 33(2), 349 — 365.
  • Fingeroth, JD., Roth, R.S., Talcott, J.A. and Rinaldi, M.G. (1994) "Zygomycosis due to Mucor circinelloides in a neutropenic patient receiving chemotherapy for acute myelogenous leukemia", Clinical Infectious Diseases, 19(1), 135— 137.
  • Funada, H. and Matsuda, T. (1990) "Pulmonary mucormycosis in a hematology ward", Internal Medicine, 35(7), 540— 544.
  • Galetta, S.L., Wulc, A.E., Goldberg, HI., Nichols, C.W. and Glaser, J.S. (1990) "Rhinocerebral mucormycosis: management and survival after carotid occlusion", Annals of Neurology, 28(1), 103–107.
  • Gamba, J.L., Woodruff, W.W., Djang, W.T. and Yeats, A.E. (1986) "Craniofacial mucormycosis: assessment with CT", Radi-ology, 160, 207 — 212.
  • Glazer, M., Nusair, S., Breuer, R., Lafair, J., Sherman, Y. and Berkman, N. (2000) "The role of BAL in the diagnosis of pulmonary mucormycosis", Chest, 117(1), 279 — 282.
  • Gonzalez, CE., Couriel, D.R. and Walsh, T.J. (1997) "Dissemi-nated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte-colony-stimulating factor", Clinical Infectious Diseases, 24(2), 192–196.
  • Harris, N.L., McNeely, W.F., Shepard, J.-A.O., Ebeling, S.H., Ellender, S.M. and Peters, C.C. (2002) "Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises", New England Journal of Medicine, 346(12), 924–929.
  • Herbrecht, R., Letscher-Bru, V., Bowden, R.A., Kusne, S, Anaissie, E.J., Graybill, J.R., et al. (2001) "Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal disper-sion", European Journal of Clinical Microbiology & Infectious Diseases, 20, 460–466.
  • Hermann, S., Klein, S.A., Jacobi, V., Thalhammer, A., Bialleck, H., Duchscherer, M., et al. (2001) "Older patients with high-risk fungal infections can be successfully allografted using non-myeloablative conditioning in combination with intensified sup-portive care regimens", British Journal of Haematology, 113, 446 — 454.
  • Hicks, W.L., Nowels, K. and Troxel, J. (1995) "Primary cutaneous mucormycosis", American Journal of Otolaryngology, 16(4), 265 — 268.
  • Ingram, C.W., Sennesh, J., Cooper, J.N. and Perfect, J.R. (1989) "Disseminated zygomycosis: report of four cases and review", Reviews of Infectious Diseases, 11(5), 741 —747.
  • Kalayjian, R.C., Herzig, R.H., Cohen, A.M. and Hutton, M.C. (1998) "Thrombosis of the aorta caused by mucormycosis", South Medical Journal, 81(9), 1180–1182.
  • Khardori, N., Hayat, S., Rolston, K. and Bodey, G.P. (1989) "Cutaneous Rhizopus and Aspergillus infections in five patients with cancer", Archives of Dermatology, 125, 952 — 956.
  • Kitabayashi, A., Hirokawa, M., Yamaguchi, A., Takatsu, H. and Miura, A.B. (1998) "Invasive pulmonary mucormycosis with rupture of the thoracic aorta", American Journal of Hematology, 58(4), 326–329.
  • Kontoyianis, D.P., Vartivarian, S., Anaissie, E.J., Samonis, G., Bodey, G.P. and Rinaldi, M. (1994) "Infections due to Cunning-hamella bertholletiae in patients with cancer: report of three cases and review", Clinical Infectious Diseases, 18(6), 925–928.
  • Langmayr, ii., Schwarz, A., Buchberger, W., Hochleitner, W. and Twerdy, K. (1993) "Local amphotericin for fungal brain abscess", Lancet, 342(8863), 123.
  • Lerchmüller, C., Goner, M., Büchner, T. and Berdel, W.E. (2001) "Rhinocerebral zygomycosis in a patient with acute lymphoblastic leukemia", Annals of Oncology, 12, 415–419.
  • Lopes, J.0., Pereira, D.V., Streher, L.A., Fenalte, A.A., Alves, S.H. and Benevenga, J.R. (1995) "Cutaneous zygomycosis caused by Absidia corymbifera in a leukemic patient", Mycopathologica, 130(2), 89–92.
  • Ma, B., Seymour, J.F., Januszewicz, H. and Slavin, M.A. (2001) "Cure of pulmonary Rhizomucor pusillus infection in a patient with hairy-cell leukaemia: role of liposomal amphotericin B and GM-CSF", Leukemia & Lymphoma, 42(6), 1393–1399.
  • Mamlok, V., Cowan, W.T. Jr. and Schnadig, V. (1987) "Unusual histopathology of mucormycosis in acute myelogenous leukae-mia", American Journal of Clinical Pathology, 88(1), 117 — 120.
  • Mathur, S.C., Friedmann, H.D., Kende, AT., Davis, R.L. and Graziano, S.L. (1999) "Cryptic Mucor infection leading to massive cerebral infarction at initiation of antileukemic chemotherapy", Annals of Hematology, 78(5), 241 —245.
  • McAlpine, L.G., Williams, D.J. and Dagg, J.H. (1987) "Breast cancer, chronic lymphocytic leukaemia and mucormycosis", Scottish Medical Journal, 32(5), 150— 151.
  • Mir, N., Edmonson, R., Yeghen, T. and Rashid, H. (2000) "Gastrointestinal mucormycosis complicated by arterio-enteric fistula in a patient with non-Hodgkin's lymphoma", Clinical and Laboratory Haematology, 22(1), 41–44.
  • Mileshlcin, L., Slavin, M., Seymour, J.F. and McKenzie, A. (2001) "Successful treatment of rhinocerebral zygomycosis using liposo-mal nystatin", Leukemia & Lymphoma, 42(5), 1119 — 1123.
  • Mohsenipour, I., Schirmer, M., Frank, R., Geisen, F., Semenitz, E., zur Nedden, D., et al. (1996) "Local application of antimycotics in mucormycosis cerebri: a case report", Journal of Neurology, Neurosurgery, and Psychiatry, 61(5), 521–522.
  • Moses, A.E., Rahav, G., Barenholz, Y., Elidan, J., Azaz, B., Gillis, S., et al. (1998) "Rhinocerebral mucormycosis treated with amphotericin B colloidal dispersion in three patients", Clinical Infectious Diseases, 26(6), 1430— 1433.
  • Ng, T.T., Campbell, C.K., Rothera, M., Houghton, J.B., Hughes, D. and Denning, D.W. (1994) "Successful treatment of sinusitis caused by Cunninghamella bertholletiae", Clinical Infectious Dis-eases, 19(2), 313–316.
  • Pefias Rios, L., de la Cámara, R., Fraga, J. and Dauden, E. (1995) "Cutaneous lesion as the first sign of disseminated mucormycosis", Acta Dermato-Venereologica, 75, 166–167.
  • Raj, P., Vella, E.J. and Bickerton, R.C. (1998) "Successful treatment of rhinocerebral mucormycosis by a combination of aggressive surgical debridement and the use of systemic liposomal amphotericin B and local therapy with nebulized amphotericin B — a case report", Journal of Laryngology and Otology, 112(4), 367— 370.
  • Rangel-Guerra, R.A., Martinez, H.R., Saenz, C., Bosques-Padilla, F. and Estrada-Bellmann, I. (1996) "Rhinocerebral and systemic mucormycosis: Clinical experience with 36 cases", Journal of Neurological Science, 143(1 — 2), 19— 30.
  • Rickerts, V., Böhme, A., Viertel, A., Behrendt, G., Jacobi, V., Tintelnot, K., et al. (2000) "Cluster of pulmonary infections caused by Cunninghamella bertholletiae in immunocompromised pa-tients", Clinical Infectious Diseases, 31(4), 910–913.
  • Robinson, BE., Stark, MT., Pope, T.L., Stewart, F.M. and Donowitz, G.R. (1990) "Cunninghamella bertholletiae: an unusual agent of zygomycosis", Southern Medical Journal, 83(9), 1088 — 1091.
  • Rubin, S.A., Chaljub, G., Winer-Muram, H.T. and Flicker, S. (1992) "Pulmonary zygomycosis: a radiographic and clinical spectrum", Journal of Thoracic Imaging, 7(4), 85–90.
  • Ryan, R.M. and Warren, R.E. (1987) "Rhinocerebral mucormy-cosis due to Absidia corymbifera", Infection, 15, 120–121.
  • Sahin, B., Payda§, S., Co§ar, E., Bieakei, K. and Hazar, B. (1996) "Role of granulocyte colony-stimulating factor in the treatment of mucormycosis", European Journal of Clinical Microbiology & Infectious Diseases, 15, 866–869.
  • Salisbury, P.L. 3rd, Caloss, R. Jr, Cruz, J.M., Powell, B.L., Cole, R. and Kohut, R.L. (1997) "Mucormycosis of the mandible after dental extractions in a patient with acute myelogenous leukaemia", Oral Surgery, Oral Medicine, and Oral Pathology, Oral Radiology and Endodontics, 83(3), 340–344.
  • Schuster, M.G. and Stern, J. (1995) "Zygomycosis orbital apex syndrome in association with solitary lung carcinoma", Journal of Medical & Veterinary Mycoloy, 33, 73–75.
  • Scully, RE., Mark, E.J., McNeely, W.F., Ebeling, S.H. and Ellender, S.M. (1999) "Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 22–1999. A 68-years-old woman with multiple myeloma, diabetes mellitus, and an inflamed eye", New England Journal of Medicine, 341(4), 265 — 273.
  • Seiff, SR., Choo, P.H. and Carter, S.R. (1999) "Role of local amphotericin B therapy for sino-orbital fungal infections", Ophthalmic Plastic and Reconstructive Surgery, 15(1), 28— 31.
  • Severo, L.C., Job, F. and Mattos, T.C. (1991) "Systemic zygomycosis: nosocomial infection by Rhizomucor pusillus", Mycopathologica, 113, 79–80.
  • Shamji, F.M., Leduc, J.R., Bormanis, J. and Sachs, H.J. (1988) "Acute Pancoast's syndrome caused by fungal infection", Cana-dian Journal of Surgery, 31(6), 441–443.
  • Shpitzer, T., Stern, Y., Anavi, Y., Segal, K. and Feinmesser, R. (1995) "Mucormycosis: experience with 10 patients", Clinical Otolaryngology, 20, 374–379.
  • Slavin, MA., Kannan, K., Buchanan, MR., Sasadeusz, J. and Roberts, A.W. (2002) "Successful allogeneic stem cell transplant after invasive pulmonary zygomycosis", Leukemia & Lymphoma, 43(2), 437–439.
  • Sohail, MA., Al Khabori, M., Hyder, J. and Verma, A. (2001) "Acute fulminant fungal sinusitis: clinical presentation, radiologi-cal findings and treatment", Acta Tropica, 80(2), 177— 185.
  • Sponsler, TA., Sassani, J.W., Johnson, L.N. and Towfighi, J. (1992) "Ocular invasion in mucormycosis", Survey of Ophthalmol-ogy, 36(5), 345–350.
  • Suh, W.I., Park, CS., Lee, M.S., Lee, J.H., Chang, M.S., Woo, J.H., et al. (2000) "Hepatic and small bowel mucormycosis after chemotherapy in a patient with acute lymphocytic leukaemia", Journal of Korean Medical Science, 15, 351–354.
  • Szelényi, H., Foss, H.D., Kreuser, ED., Knauf, W. and Thiel, E. (1996) "Fatal Mucor pneumonia after treatment with 2-chloro-deoxyadenosine for non-Hodgkins-lymphoma", Annals of Hema-tology, 73, 145–157.
  • Schuster, M.G. and Stern, J. (1995) "Zygomycosis orbtial apex syndrome in association with a solitary lung carcinoma", Journal of Medical and Veterinary Mycology, 33(1), 73–75.
  • St-Germain, G., Robert, A., Ishak, M., Tremblay, C. and Claveau, S. (1993) "Infection due to Rhizomucor pusillus: report of four cases in patients with leukaemia and review", Clinical Infectious Diseases, 16(5), 640–645.
  • Tedeschi, A., Montillo, M., Cairoli, R., Mareno, P., Cafro, A., Oreste, P., et al. (2002) "Prior invasive pulmonary and cerebellar mucormycosis is not a primary contraindication to perform an autologous stem cell transplantation in leukemia", Leukemia & Lymphoma, 43(3), 657 — 659.
  • ter Borg, F., Kuijper, E.J. and van der Lelie, H. (1990) "Fatal mucormycosis presenting as an appendiceal mass with metastatic spread to the liver during chemotherapy-induced granulocytope-nia", Scandinavian Journal of Infectious Diseases, 22(4), 499–501.
  • Umbert, I.J. and Wu, W.P. (1989) "Cutaneous mucormycosis", Journal of the American Academy of Dermatology, 21(6), 1232 — 1234.
  • Vallaeys, J.H., Praet, MM., Roels, H.J., van Marck, E. and Kaufman, L. (1989) "The Budd-Chiari syndrome caused by a zygomycete. A new pathogenesis of hepatic vein thrombosis", Archives of Pathology & Laboratory Medicine, 113(10), 1171–1174.
  • Ventura, G.J., Kantarjian, H.M., Anaissie, E., Hopfer, R.L. and Fainstein, V. (1986) "Pneumonia with Cunninghamella species in patients with hematologic malignancies", Cancer, 58, 1534–1536.
  • Walsh, T.J., Ranshaw, G., Andrews, J., Kwon-Chung, J., Cunnion, R.C., Pass, H.J., et al. (1994) "Invasive zygomycosis due to Conidiobolus incongruous", Clinical Infectious Diseases, 19(3), 423–430.
  • Weng, D.E., Wilson, W.H., Little, R. and Walsh, T.J. (1998) "Successful medical management of isolated renal zygomycosis: case report and review", Clinical Infectious Diseases, 26(3), 610 — 615.
  • Yamauchi, T., Misalci, H., Arai, H., Iwasaki, H., Naiki, H. and Ueda, T. (2002) "An autopsy case of disseminated mucormycosis in a neutropenic patient receiving chemotherapy for the underlying solid malignancy", Journal of Infection and Chemotherapy, 8(1), 103 — 105.
  • Zapatero, J., Flandes, J., Ruiz-Zafra, J., Fogue, L., Salvatierra, S., Saldana, D., et al. (1995) "Bronchovascular mucormycosis: an urgent surgical problem", European Journal of Cardiothoracic Surgery, 9(5), 286–288.
  • Zarei, M., Morris, J., Aachi, V., Gregory, R., Meanock, C. and Brito-Babapullae, F. (2000) "Acute isolated cerebral mucormyco-sis in a patient with high grade non-Hodgkins lymphoma", European Journal of Neurology, 7(4), 443–447.
  • Kontoyiannis, D.P., Wessel, V.C., Bodey, G.P. and Rolston, KN. (2000) "Zygomycosis in the 1990s in a tertiary-care cancer center", Clinical Infectious Diseases, 30, 851 — 856.
  • Yohai, R.A., Bullock, J.D., Aziz, A.A. and Markert, R.J. (1994) "Survival factors in rhino-orbital-cerebral mucormycosis", Survey of Ophthalmology, 39(1), 3–22.
  • Ascioglu, S., Rex, J.H., de Pauw, B., Bennett, J.E., Bille, J., Corkaert, F., et al. on behalf of the Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. (2002) "Defining opportunistic invasive fungal infections in immunocom-promised patients with cancer and hematopoietic stem cell transplants: an international consensus", Clinical Infectious Dis-eases, 34, 7–14.
  • Chakrabarti, A., Das, A., Sharma, A., Panda, N., Das, S., Gupta, K.L., et al. (2001) "Ten years' experience in zygomycosis at a tertiary care centre in India", Journal of Infection, 42(4), 261–266.
  • Rinaldi, M.G. (1989) "Zygomycosis", Infectious Disease Clinics of North America, 3(1), 19–41.
  • Talmi, Y.P., Goldschmied-Reouven, A., Bakon, M., Barshack, I., Wolf, M., Horowitz, Z., et al. (2002) "Rhino-orbital and rhino-orbito-cerebral mucormycosis", Otolaryngology Head and Neck Surgery, 127(1), 22–31.
  • Maniglia, A.J., Mintz, D.H. and Novak, S. (1982) "Cephalic phycomycosis: a report of eight cases", Laryngoscope, 92, 755 — 760.
  • Blitzer, A., Lawson, W., Meyers, B.R. and Biller, H.F. (1980) "Patient survival factors in paranasal sinus mucormycosis", Laryngoscope, 90, 635–648.
  • Hay, R.J. (1994) "Liposomal amphotericin B, AmBisome", Journal of Infection, 28(Supp I), 35–43.
  • Leenders, AC., Daenen, S., Jansen, R.L., Hop, W.C., Lowenberg, B., Wijermans, P.W., et al. (1998) "Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections", British Journal of Haematology, 103, 205–212.
  • Wong-Beringer, A., Jacobs, R.A. and Guglielmo, B.J. (1998) "Lipid formulations of amphotericin B: clinical efficacy and toxicities", Clinical Infectious Diseases, 27, 603–618.
  • Leenders, CAP., Daenen, S., Jansen, R.J.H., Hop, W.C.J., Lowenberg, B., Wijermans, P.M., et al. (1998) "Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-asso-ciated fungal infections", British Journal of Haematology, 103, 205— 212.
  • Wingard, J.R., White, M.H., Anaissie, E., Raffalli, J., Goodman, J., Arrieta, A. and the L Amph/ABLC Collaborative Study Group. (2000) "A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia", Clinical Infectious Diseases, 31, 1155 — 1163.
  • Bodey, G.P., Anaissie, E., Gutterman, J. and Vadhan-Raj, S. (1993) "Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer", Clinical Infectious Diseases, 17, 705–707.
  • Garzia-Diaz, J.B., Palau, L. and Pankey, G.A. (2001) "Resolution of rhinocerebral zygomycosis associated with adjuvant adminis-tration of granulocyte-macrophage colony-stimulating factor", Clinical Infectious Diseases, 32, 166–170.
  • Dignani, M.C., Anaissie, E.J., Hester, J.P., O'Brien, S., Vartivar-ian, SE., Rex, J.H., et al. (1997) "Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study", Leukemia, 11, 1621–1630.
  • Nussbaum, E.S. and Hall, W.A. (1994) "Rhinocerebral mucormy-cosis: changing patterns of disease", Surgical Neurology, 41(2), 152–156.
  • Boelart, J.R. (1994) "Mucormycosis (zygomycosis): is there news for the clinicians?", Journal of Infection, 28\(Supp 1), 1–6.
  • Mirsky, H.S. and Cutter, J. (1972) "Fungal infection in acute leukemia", Cancer, 30(2), 348 — 352.
  • Dannaoui, E., Mouton, J.W., Meis, J.F. and Verweij, P.E. (2002) "Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis", Antimicrobial Agents and Chemotherapy, 46(6), 1953— 1959.
  • Mosquera, J., Warn, PA., Rodriguez-Tudela, J.L. and Denning, D.W. (2001) "Treatment of Absidia corymbifera infection in mice with amphotericin B and intraconazole", Journal of Antimicrobial Chemotherapy, 48(4), 583— 586.
  • Parthiban, K., Gnanaguruvelan, S., Janalci, C., Sentamilselvi, G. and Boopalraj, J.M. (1998) "Rhinocerebral zygomycosis", Myco-sis, 41, 51–53.
  • Kumar, B., Kaur, I., Chakrabarti, A. and Sharma, V.K. (1991) "Treatment of deep mycoses with itraconazole", Mycopathologia, 115, 169 — 174.
  • Hunter, A.J. and Bryant, R.E. (2002) "Abdominal wall mucormy-cosis successfully treated with amphotericin and itraconazole", Journal of Infection, 44(3), 203 — 204.
  • Espinel-Ingroff, A. (2001) "In-vitro fungicidal activities of vor-iconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi", Journal of Clinical Micro-biology, 39(3), 954–958.
  • Johnson, EM., Szekely, A. and Warnock, D.W. (1998) "In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi", Journal of Antimicrobial Chemotherapy, 42, 741 —745.
  • Chiou, CC., Groll, A.H. and Walsh, Ti. (2000) "New Drugs and novel targets for treatment of invasive fungal infections in patients with cancer", Oncologist, 5, 120–135.
  • Pfaller, M.A., Messer, S.A., Hollis, R.J., Jones, RN. and SENTRY Participants Group. (2000) "Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000", Antimicrobial Agents and Chemotherapy, 46(4), 1032— 1037.
  • Sun, Q.N., Najvar, L.K., Bocanegra, R., Loebenberg, D. and Graybill, J.R. (2002) "In vivo activity of posaconazoel against Mucor spp. in an immunosuppressed-mouse model", Antimicrobial Agents and Chemotherapy, 46(7), 2310–2312.
  • Sun, Q.N., Fothergill, A.W., McCarthy, DI., Rinaldi, M.G. and Garybill, J.R. (2002) "In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes", Antimicrobial Agents and Chemotherapy, 46(5), 1581–1582.
  • Dannaoui, E., Meletiadis, J., Mouton, J.W., Meis, J.F.G.M., Verweij, P.E. and the Eurofung Network. (2003) "In vitro susceptibilites of zygomycetes of conventional and new antifun-gals", Journal of Antimicrobial Chemotherapy, 51, 45 — 52.
  • Tobon, A.M., Arango, M., Fernandez, D. and Restrepo, A. (2003) "Mucormycosis (zygomycosis) in a heart-kidney transplant re-cipient: recovery after posaconazole therapy", Clinical Infectious Diseases, 36(11), 1488–1491.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.